Overview
NICE is unable to make a recommendation on depemokimab (Exdensur) for treating chronic rhinosinusitis with nasal polyps in adults. This is because the company did not provide an evidence submission.
Last reviewed: 22 January 2026
Next review: We will review this decision if the company decides to make a submission.